» Authors » Moriah P Bellissimo

Moriah P Bellissimo

Explore the profile of Moriah P Bellissimo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 190
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Bellissimo M, Fleischer C, Reiter D, Goss A, Zhou L, Smith M, et al.
Nutr Metab (Lond) . 2022 May; 19(1):37. PMID: 35597962
Background: Adiposity and mitochondrial dysfunction are related factors contributing to metabolic disease development. This pilot study examined whether in vivo and ex vivo indices of mitochondrial metabolism were differentially associated...
12.
Liu K, Owens J, Saeedi B, Cohen C, Bellissimo M, Naudin C, et al.
Nat Metab . 2021 Dec; 3(12):1694-1705. PMID: 34931082
Obesity and obesity-related metabolic disorders are linked to the intestinal microbiome. However, the causality of changes in the microbiome-host interaction affecting energy metabolism remains controversial. Here, we show the microbiome-derived...
13.
Bellissimo M, Hsu E, Hao L, Easley K, Martin G, Ziegler T, et al.
J Clin Transl Endocrinol . 2021 Jun; 24:100257. PMID: 34178605
Background: A significant proportion of adults have normal weight obesity (NWO), defined as a normal body mass index (BMI) but disproportionately high body fat percentage. Individuals with NWO may have...
14.
Bellissimo M, Jones D, Martin G, Alvarez J, Ziegler T
JPEN J Parenter Enteral Nutr . 2021 Jun; 45(8):1635-1644. PMID: 34111906
Background: Rapid loss of lean mass during catabolic states is associated with impaired convalescence and increased mortality rates. An understanding of metabolic pathways related to lean mass is needed to...
15.
Bellissimo M, Roberts J, Jones D, Liu K, Taibl K, Uppal K, et al.
Nutrients . 2020 Oct; 12(10). PMID: 33081124
Bone is a dynamic tissue that is in a constant state of remodeling. Bone turnover markers (BTMs), procollagen type I N-terminal propeptide (P1NP) and C-terminal telopeptides of type I collagen...
16.
Bellissimo M, Bettermann E, Tran P, Crain B, Ferranti E, Binongo J, et al.
J Acad Nutr Diet . 2020 Oct; 120(12):1963-1973.e2. PMID: 33011149
Background: Individuals with normal weight obesity (NWO) have increased cardiometabolic disease and mortality risk, but factors contributing to NWO development are unknown. Objective: The objective of this study was to...
17.
Cioffi C, Narayan K, Liu K, Uppal K, Jones D, Tran V, et al.
BMJ Open Diabetes Res Care . 2020 Jul; 8(1). PMID: 32699106
Introduction: Body fat distribution is strongly associated with cardiometabolic disease (CMD), but the relative importance of hepatic fat as an underlying driver remains unclear. Here, we applied a systems biology...
18.
Bellissimo M, Ziegler T, Jones D, Liu K, Fernandes J, Roberts J, et al.
Clin Nutr . 2020 Jul; 40(2):467-475. PMID: 32620447
Background & Aims: There is a considerable degree of variation in bone mineral density (BMD) within populations. Use of plasma metabolomics may provide insight into established and novel determinants of...
19.
Bellissimo M, Cai Q, Ziegler T, Liu K, Tran P, Vos M, et al.
Obesity (Silver Spring) . 2019 Nov; 27(11):1729-1737. PMID: 31689010
Objective: This study explored underlying metabolism-related dysfunction by examining metabolomic profiles in adults categorized as lean, as having normal weight obesity (NWO), or as having overweight/obesity. Methods: Participants (N = ...
20.
Bellissimo M, Zhang I, Ivie E, Tran P, Tangpricha V, Hunt W, et al.
J Cyst Fibros . 2019 Jan; 18(3):430-435. PMID: 30665857
Background: Body fat distribution and diet quality influence clinical outcomes in general populations but are understudied in individuals with cystic fibrosis (CF). The aim of this pilot study was to...